The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.

Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano A, DeKosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P, de Haan W, Grundman M, van Dyck CH, Izzo NJ, Catalano SM, Synaptic Health Endpoints Working Group

Open source

DOI: 10.1186/s13195-020-00588-4
Published: 2020 Mar 2
Container: Alzheimer's research & therapy
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13195-020-00588-4,
  title = {The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.},
  author = {Colom-Cadena M and Spires-Jones T and Zetterberg H and Blennow K and Caggiano A and DeKosky ST and Fillit H and Harrison JE and Schneider LS and Scheltens P and de Haan W and Grundman M and van Dyck CH and Izzo NJ and Catalano SM and Synaptic Health Endpoints Working Group},
  year = {2020},
  journal = {Alzheimer's research \& therapy},
  doi = {10.1186/s13195-020-00588-4},
  url = {https://doi.org/10.1186/s13195-020-00588-4}
}

RIS

TY  - JOUR
TI  - The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
AU  - Colom-Cadena M
AU  - Spires-Jones T
AU  - Zetterberg H
AU  - Blennow K
AU  - Caggiano A
AU  - DeKosky ST
AU  - Fillit H
AU  - Harrison JE
AU  - Schneider LS
AU  - Scheltens P
AU  - de Haan W
AU  - Grundman M
AU  - van Dyck CH
AU  - Izzo NJ
AU  - Catalano SM
AU  - Synaptic Health Endpoints Working Group
PY  - 2020
JO  - Alzheimer's research & therapy
DO  - 10.1186/s13195-020-00588-4
UR  - https://doi.org/10.1186/s13195-020-00588-4
ER  -

APA

M, C., T, S., H, Z., K, B., A, C., ST, D., H, F., JE, H., LS, S., P, S., W, D. H., M, G., CH, V. D., NJ, I., SM, C., & Group, S. H. E. W. (2020). The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.. Alzheimer's research & therapy. https://doi.org/10.1186/s13195-020-00588-4

Source records

pubmed · retrieved 2026-09-26T06:05:14.999Z
europe-pmc · retrieved 2026-09-26T06:05:15.008Z
doaj · retrieved 2026-09-26T06:05:14.990Z